Delivery Order SPE2DB22D3301-SPE2DB25FY4LM
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,501.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for GADAVIST 10 MMOL/10 ML VIAL 10ML, with an ultimate completion date of April 10, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,828.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 mL vial of a 10 mmol/mL solution, with a performance period ending on May 6, 2025. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $1,180.34 firm fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Gadavist 1 mmol/ml bulk vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Gadavist 1 mmol/ml bulk vial (30 ml). The firm-fixed-price delivery order, valued at $4,546.40, has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gadavist 1 mmol/ml bulk vial (30 ml), a pharmaceutical product, at a firm fixed price of $1,704.90. The contract has an ultimate completion date of May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,165.20 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award date is April 1, 2024, with an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery...
This federal contract award with ID SPE2DB22D3301|SPE2DB25FX4WQ was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,711.35 firm fixed price delivery order is for the pharmaceutical product Gadavist 1 mmol/ml bulk vial 30ml. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,233.00, is for the delivery of Gadavist 7.5 mmol/7.5 ml vials, a medical imaging agent. The contract has an ultimate completion date of May 30, 2024 and is structured as a Firm Fixed Price Delivery Order. There is no set-aside designation noted. AmerisourceBergen holds a larger $999,999,999...
This federal contract award, valued at $1,711.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The specific item being procured is 4565561871...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,962.44, is for the supply of Gadavist, a 10 mmol/10 ml vial medication, with a period of performance through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...